Form D · Biotechnology
Synergenetics Bioscience Inc.
Vancouver, A1 · CIK 0001800452
Offering snapshot reported Mar 30, 2020 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 20, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2020 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jan 28, 2020 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jan 22, 2020 | Initial | $2,670 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-363878
Source: Form D, filed Mar 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cong Chen | Director, Executive |
| Chong Chen | Executive |
| Ping Zhang | Director, Executive |
| Ling Zhang | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11001 Granville Avenue
Vancouver, A1, V6Y 1R7
Vancouver, A1, V6Y 1R7